Kinesin inhibitor, K 858, Purity ≥98%

Cat. No.: X24-08-YM326

Kinesin inhibitor, K 858, Purity ≥98%

Synonym: 72926-24-0; K-858; K858; N-(4-Acetyl-5-methyl-5-phenyl-1,3,4-thiadiazol-2-yl)acetamide

  • MDL: MFCD00181155
  • CAS Number: 72926-24-0
  • Compound CID: 2930014
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
K 858, soluble in DMSO and ethanol and insoluble in water, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting kinesin. It targets the Eg5.
Molecular Weight
277.34
Molecular Formula
C13H15N3O2S
Targets
Eg5: 1.3 μM (IC50)
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 53 mg/mL (191.1 mM); Water: insoluble; Ethanol: 4 mg/mL (14.42 mM)
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
K 858 is a cytoskeletal signaling inhibitor that plays a key role in disrupting mitotic spindle formation, which can lead to cancer cell death.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.